全文获取类型
收费全文 | 258篇 |
免费 | 15篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 24篇 |
妇产科学 | 1篇 |
基础医学 | 31篇 |
口腔科学 | 1篇 |
临床医学 | 5篇 |
内科学 | 13篇 |
皮肤病学 | 1篇 |
神经病学 | 8篇 |
外科学 | 3篇 |
综合类 | 8篇 |
预防医学 | 152篇 |
眼科学 | 1篇 |
药学 | 17篇 |
肿瘤学 | 7篇 |
出版年
2023年 | 3篇 |
2022年 | 7篇 |
2021年 | 14篇 |
2020年 | 15篇 |
2019年 | 8篇 |
2018年 | 14篇 |
2017年 | 7篇 |
2016年 | 10篇 |
2015年 | 10篇 |
2014年 | 8篇 |
2013年 | 11篇 |
2012年 | 15篇 |
2011年 | 16篇 |
2010年 | 18篇 |
2009年 | 8篇 |
2008年 | 11篇 |
2007年 | 14篇 |
2006年 | 11篇 |
2005年 | 8篇 |
2004年 | 6篇 |
2003年 | 3篇 |
2002年 | 2篇 |
2001年 | 1篇 |
2000年 | 8篇 |
1999年 | 6篇 |
1998年 | 6篇 |
1997年 | 4篇 |
1996年 | 4篇 |
1995年 | 4篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1985年 | 2篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1973年 | 2篇 |
排序方式: 共有274条查询结果,搜索用时 15 毫秒
1.
Profound reductions in cortical acetylcholine levels together with degeneration of cholinergic neurons in the basal forebrain have been reported in patients with Alzheimer's disease. A similar loss of the cholinergic neurons of the basal forebrain and impairment of learning and memory occur in animals injected with a nerve growth factor-diphtheria toxin conjugate, suggesting that this animal model is suitable to analyze cholinergic roles on learning and memory processes, and also the pathogenesis of Alzheimer's disease. In addition, animal models constructed by electrolytic or neurotoxic lesioning of the basal magnocellular nucleus, and models made by transgenetic technology were described. 相似文献
2.
Henrik Aggerbeck Bent Nørgaard-Pedersen Iver Heron 《Journal of immunological methods》1996,190(2):171-183
A dual, double antigen, time-resolved fluorescence immunoassay (DELFIA) for the simultaneous detection and quantitation of diphtheria (D) and tetanus (T) antibodies in sera has been developed. In the double antigen format one arm of the antibody binds to antigen coated microtitre wells and the other arm binds to labelled antigen to provide a fluorescent signal. This assay was found to be functionally specific for IgG antibodies and showed a good correlation with established toxin neutralization assays. Furthermore, the double antigen set-up was species independent, permitting the direct use of existing international references of animal origin to measure protective antibody levels in humans in international units (IU/ml). The detection limit corresponded to 0.0003 IU/ml with Eu3+-labelled toxoids and to 0.0035 IU/ml using Sm3+-labelled toxoids. The assay was fast with a high capacity making it a suitable method for serological surveillance studies. 相似文献
3.
Pierre Marschall Ruicheng Wei Justine Segaud Wenjin Yao Pierre Hener Beatriz Falcon German Pierre Meyer Cecile Hugel Grace Ada Da Silva Reinhard Braun Daniel H. Kaplan Mei Li 《The Journal of allergy and clinical immunology》2021,147(5):1778-1794
- Download : Download high-res image (187KB)
- Download : Download full-size image
4.
5.
《Vaccine》2021,39(34):4778-4783
Current international guidelines recommend routinely vaccinating haematopoetic stem cell transplant (HSCT) recipients. Despite significant infection-related mortality following autologous HSCT, routine vaccination programmes (RVP) completion is poor. For recovered HSCT recipients, it is uncertain whether catch-up vaccination remains worthwhile years later.To determine potential susceptibility to vaccine preventable infections, we measured antibody titres in 56 patients, a median of 7 years (range 0–29) following autologous HSCT, who had not completed RVP. We found that almost all participants had inadequate titres against diphtheria (98.2%) and pneumococcal infection (100%), and a significant proportion had inadequate titres against measles (34.5%). Of those subsequently vaccinated according to available guidelines, many mounted adequate serological responses.These data suggest a pragmatic catch-up approach for autologous HSCT recipients who have not completed RVP is advisable, with universal vaccination against some pathogens (e.g. Streptococcus pneumoniae and diphtheria) and serologically-guided approaches for others (e.g. measles and varicella zoster virus). 相似文献
6.
Techniques of time series analysis were used to examine historical records of the incidence of diphtheria, pertussis, and measles, and of deaths by measles in Portugal during the twentieth century. There are statistically significant seasonal and long-term oscillations in the incidence of these diseases. Seasonal oscillations appear to be in close association with the resumption of school classes in the fall in the case of diphtheria, but not in pertussis and measles. Long-term oscillations in pertussis (3.5–4 year period) and measles (3-year period), before vaccination, corroborate theoretical predictions about the dynamics of these diseases, whereas absence of long-term oscillations in diphtheria is probably due to the influential presence of carriers upon the dynamics of the disease. Mass vaccination strongly suppressed disease incidence, did not eliminate seasonal oscillations, and appeared to have acted to lengthen long-term periodicity in pertussis and measles. 相似文献
7.
H. J. Schmitt F. Zepp S. Müschenborn G. Sümenicht A. Schuind K. Beutel M. Knuf H. L. Bock H. Bogaerts R. Clemens 《European journal of pediatrics》1998,157(3):208-214
With an increasing number of new vaccines available for routine childhood immunization, combination vaccines are needed in
order to maintain or achieve a high compliance with recommended immunization programmes. In a prospective, randomized, comparative,
multi-centre study, 822 healthy infants were enrolled to receive three doses of either a candidate or a commercially available
Haemophilus influenzae type b (Hib) vaccine concomitantly with diphtheria-, tetanus- acellular pertussis (DTaP) vaccine. Study subjects were randomly
allocated to one of the following groups: (1) separate, or (2) mixed injection of DTaP and candidate Hib vaccine, or (3) separate
injection of DTaP and commercial Hib vaccine. One year later the first 189 study subjects received either separate or mixed
injections of the same Hib and DTaP vaccines as booster doses. Evaluation of reactogenicity was based on diary cards completed
by parents. Immunogenicity was documented by measuring IgG antibody concentrations in serum samples taken before and 4 weeks
after primary and booster vaccination. No serious adverse events occurred and most local and systemic reactions were mild
to moderate. Booster doses were more reactogenic than primary doses with all groups. Antibody concentrations against pertussis
antigens were similar to those seen with DTaP alone. All but one subject had protective antibody concentrations against diphtheria
and tetanus. Primary immune response to the Hib vaccine was significantly lower in the group receiving the mixed Hib-DTaP
vaccine, however, ≥95% of vaccinees had anti-Hib antibody concentrations ≥0.15 μg/ml and there was a marked booster response
(>100-fold) in all groups.
Conclusions Mixing DTaP and Hib vaccines for primary immunization caused a decrease in anti-Hib antibody response, although after primary
immunization as after booster doses, all subjects showed antibody concentrations considered to be protective for invasive
Hib disease. Mixing of the vaccines did not result in increased reactogenicity.
Received: 13 June 1997 / Accepted in revised form: 4 September 1997 相似文献
8.
《Vaccine》2015,33(31):3717-3725
Prior study children from a DTaP efficacy trial were recruited at ages 5 and 15 years to randomized booster trials addressing immunogenicity and reactogenicity; 475 preschool children received mixed or separate injections of a reduced antigen vaccine (Tdap5, Sanofi Pasteur MSD) and an inactivated polio vaccine, and 230 adolescents received the same or another booster vaccine (Tdap1, SSI, Denmark).Pre-vaccination antibody concentrations against pertussis antigens were significantly higher at 15 than 5 years of age, probably due to natural boosting between the studies. Tdap5 induced comparable anti-PT concentrations at both ages, but antibody responses were significantly higher to filamentous haemagglutinin, pertactin and fimbriae 2/3 in adolescents. As expected, a higher amount of PT (Tdap1, 20 μg) induced a stronger anti-PT response than a lower amount (Tdap5, 2.5 μg).The frequency of adverse events was low and there were no serious adverse reactions. All local reactions had an early onset and a short duration. A large swelling or redness of more than half of the upper arm circumference was reported in 8/475 5-year-olds and in 6/230 15-year-olds. Children vaccinated with Tdap5 reported more moderate pain in adolescence than at preschool age, whereas itching was only reported in preschool children.Sweden introduced DTaP vaccines in 1996 after a 17-year hiatus with no general pertussis vaccination and pertussis was still endemic at the time of the studies. The frequency of adverse events was nevertheless low in both preschool children and adolescents and antibody responses were adequate. These studies document immunogenicity and reactogenicity in a trial cohort consecutively vaccinated with acellular pertussis vaccines from infancy to adolescence.The adolescent study was registered at ClinicalTrials.gov on 26 March 2009 (NCT00870350). 相似文献
9.
Ronald Gold Luis Barreto Santiago Ferro John Thippawong Roland Guasparini William Meekison Margaret Russell Elaine Mills Dana Harrison Pierre Lavigne 《The Canadian Journal of Infectious Diseases & Medical Microbiology》2007,18(4):241-248
OBJECTIVE: The safety, immunogenicity and lot consistency of a fully liquid, five-component acellular pertussis combination vaccine, comprised of diphteria, tetanus and acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b (DTaP-IPV-Hib [Pediacel, sanofi pasteur, Canada]) were assessed and compared with that of Hib vaccine reconstituted with the five-component acellular pertussis combination vaccine (DTaP-IPV//Hib, Pentacel [sanofi pasteur, Canada]). METHODS: Infants were recruited at vaccine study centres in Montreal, Quebec; Simon Fraser Health Region, British Columbia, and southern Alberta after the protocol had been approved by the relevant institutional ethics committees. Written informed consent was obtained from the parents or guardians of all subjects. At two months of age, the infants were randomly assigned to receive one of three consecutive production lots of DTaP-IPV-Hib by intramuscular injection. Reactions to vaccinations were assessed by parental observation and through telephone interviews conducted by study nurses. Blood samples were obtained at two, six, seven, 18 and 19 months of age for measurement of antibodies to vaccine antigens. RESULTS: Most injection site and systemic reactions were mild or moderate, and of brief duration. All infants were protected against tetanus, diphtheria and all three polio serotypes after both primary and booster vaccinations. Antibody responses to pertussis antigens were similar to those observed in Swedish infants, in whom the five-component vaccine was shown to be 85% effective. Proportions of infants with antipolyribosylribitol phosphate antibody of 0.15 mug/mL or greater and 1.0 mug/mL or greater, were 97.9% and 88.9%, respectively, following primary immunization, and 100% and 99% following booster vaccination. Safety and immunogenicity results with both reconstituted and fully liquid combination vaccines were comparable. CONCLUSIONS: The fully liquid combination vaccine was comparable in terms of safety and immunogenicity with the reconstituted combination vaccine. 相似文献
10.
靶向DF3的白喉毒素A链基因对乳腺癌细胞的杀伤作用 总被引:2,自引:1,他引:2
目的探讨白喉毒素A链(DTA)基因在DF3/MUC1启动子调控下的杀伤作用。方法构建含人乳腺癌DF3启动子和白喉毒素A链基因的表达载体pGL3-DF3-DTA,转染DF3阳性的乳癌细胞MCF-7,逆转录-聚合酶链反应(RT-PCR)检测DTA基因的表达;噻唑蓝(MTT)比色法检测细胞生长活性;免疫组织化学法和流式细胞术检测细胞凋亡。结果酶切和测序表明获得了与预期结果相一致的pGL3-DF3-DTA真核表达载体。转染MCF-7细胞后,RT-PCR检测到了249 bp的DTA mRNA片段。与对照组比较,转染pGL3-DF3-DTA的MCF-7细胞生长受到了抑制,流式细胞术检测到的凋亡率达39.43%,而对照组仅有0.28%。结论pGL3-DF3-DTA可对DF3阳性的乳癌细胞产生特异性的杀伤,对乳腺癌的基因治疗有潜在的应用价值。 相似文献